Recombinant Proteins Market

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.

Recombinant Proteins Market contains market size and forecasts of Recombinant Proteins in Global, including the following market information:

Global Recombinant Proteins Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Recombinant Proteins market was valued at 740.2 million in 2021 and is projected to reach US$ 1248.3 million by 2028, at a CAGR of 7.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormones Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Proteins include Abcam PLC, R&D Systems, Miltenyi Biotec, Thermo Fisher Scientific, Sigma Aldrich Company, GE Healthcare, Lonza, Merck KGaA and ProSpec Tany TechnoGene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Recombinant Proteins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Proteins Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Proteins Market Segment Percentages, by Type, 2021 (%)

Hormones

Growth Factors

Cytokines

Plasma Protein Factor

Recombinant Metabolic Enzymes

Immune Checkpoint Regulators

Others

Global Recombinant Proteins Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Proteins Market Segment Percentages, by Application, 2021 (%)

Biopharmaceutical Companies

Academic and Research Institutes

Contract Research Organizations

Global Recombinant Proteins Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Recombinant Proteins Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Proteins revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Recombinant Proteins revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abcam PLC

R&D Systems

Miltenyi Biotec

Thermo Fisher Scientific

Sigma Aldrich Company

GE Healthcare

Lonza

Merck KGaA

ProSpec Tany TechnoGene

Eurogentec (Kaneka Corporation)

PeproTech

BPS Bioscience

Reprocell

GenScript Biotech Corporation

Abnova Corporation